# FDA Inspection 1217144 - OrBion Pharmaceuticals Private Limited - September 08, 2023

Source: https://www.keypedia.com/records/fda_inspections/orbion-pharmaceuticals-private-limited/4a0112db-957b-4de5-a93b-486789241983
Source feed: FDA_Inspections

> FDA Inspection 1217144 for OrBion Pharmaceuticals Private Limited on September 08, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1217144
- Company Name: OrBion Pharmaceuticals Private Limited
- Inspection Date: 2023-09-08
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1289382 - 2025-10-27](https://www.keypedia.com/records/fda_inspections/orbion-pharmaceuticals-private-limited/7a98f743-d490-4a8f-a7fa-8120ad8e373a)
- [FDA Inspection 1289382 - 2025-10-27](https://www.keypedia.com/records/fda_inspections/orbion-pharmaceuticals-private-limited/fb029ccf-bd2d-43e3-bc2b-bd70115ea641)
- [FDA Inspection 1240651 - 2024-05-10](https://www.keypedia.com/records/fda_inspections/orbion-pharmaceuticals-private-limited/cad95685-62ad-41b9-9796-5d0285fe5228)
- [FDA Inspection 1091278 - 2019-05-31](https://www.keypedia.com/records/fda_inspections/orbion-pharmaceuticals-private-limited/6435cb4b-cafe-4dce-89f6-11d07f6e1b87)
- [FDA Inspection 934390 - 2015-06-03](https://www.keypedia.com/records/fda_inspections/orbion-pharmaceuticals-private-limited/badb4e3e-f173-454f-a457-af025c3b5033)

Company: https://www.keypedia.com/companies/orbion-pharmaceuticals-private-limited/1cdc049d-587c-4283-8d5c-8604cff032c9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c